Industry Research by Koncept Analytics
Global Erythropoietin (EPO) Market with Focus on Asia: Industry Analysis & Outlook ----------------------------------------(2016-2020) November 2016
Global Erythropoietin (EPO) Market with Focus on Asia: Industry Analysis & Outlook (2016-2020)
1
Executive Summary Erythropoietin is a substance produced by the kidney that leads to the formation of red blood cells in the bone marrow. It is a glycoprotein hormone which regulates erythropoiesis (Red Blood Cell production). For erythrocyte precursors present in the bone marrow, EPO acts as a cytokine. Commonly referred to as hematopoietin or hemopoietin, erythropoietin is also known to have other biological functions, such as involvement in the wound healing cycle and brain’s response to neuronal injury. People suffering from End Stage Renal Disease (ESRD), HIV or undergoing chemotherapy are not able to produce enough EPO on their own and thus, are administered with synthetic or recombinant erythropoietin which has the similar sequence of amino acids. Recombinant erythropoietin is a kind of therapeutic agent devised using DNA technology. On the bases of their molecular structure, EPO drugs can be divided into five categories: epoetin-alfa, epoetin-beta, epoetin-omega, epoetin-delta and darbepoetin-alfa. Among these epoetin-alfa and darbepoetin-alfa are most commonly prescribed EPO drugs. The global EPO drugs market is expected to experience negative growth rate, primarily due to expiry of patents of two most common EPO drugs, epoetin-alfa and darbepoetin-alfa, allowing the entry of biosimilars; posing a serious threat to EPO drugs market. However, the Asia-Pacific region is expected to experience boom period majorly due to improving disposable income and better government medical reimbursement policies. The report “Global Erythropoietin (EPO) Market with Focus on Asia: Industry Analysis & Outlook (20162020)” analyzes the development of this market, with focus on the US and Asia-Pacific markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Johnson & Johnson, Amgen, Roche and Teva Pharmaceutical Industries Limited are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global EPO market along with the study of the regional markets.
Global Erythropoietin (EPO) Market with Focus on Asia: Industry Analysis & Outlook (2016-2020)
2
Globally rising incidences of cancer, End Stage Renal Disease (ESRD) and other chronic ailments would expectedly drive growth of the global EPO market. However, the expiry of patents of epoetin-alfa in year 2015 and darbepoetin-alfa in late 2016 will have a negative impact on the overall market growth. Global EPO Drug Market by Value (2011-2015)
• •
•
Global EPO Drug Market by Value – Forecast (2016-2020)
The global EPO market reached US$... billion by the end of year 2015, recording a mild decline of ….% from previous years revenue of US$... billion. In 2016, the global EPO market will reach US$... billion and is expected to fall to US$... billion mark by 2020, declining at a CAGR of …%, spanning from 2016 to 2020. In year 2015, the US held …% share of the global EPO drug market followed by Asia-Pacific with merely …% share. However, by the end of year 2020, the market share of the US will fall to …% and Asia-Pacific will rise to …%.
Global EPO Drug Market by Region (2015/2020)
2020
Global Erythropoietin (EPO) Market with Focus on Asia: Industry Analysis & Outlook (2016-2020)
2015
3
The Asia-Pacific region is expected to experience boom period majorly due to improving disposable income and better government medical reimbursement policies. The US EPO Drug Market by Value – Forecast (2015-2020)
•
•
•
China EPO Drug Market by Value (2011-2015)
In 2015, the market was recorded at US$... billion and is expected to fall to nearly US$... billion by the end of 2020, declining at a CAGR of …%, spanning from 2015 to 2020. In 2015, the China EPO market was recorded at US$... billion, compared to US$... billion in 2014, representing an annual increment of nearly …% from the previous year. In 2015, the EPO market value of Malaysia was recorded at US$... million and is further expected to accelerate at an impressive CAGR of …%, spanning from 2015 to 2020 and reach US$... million by the end of 2020.
Malaysia EPO Drug Market by Value – Forecast (2015-2020)
Global Erythropoietin (EPO) Market with Focus on Asia: Industry Analysis & Outlook (2016-2020)
4
Contact Us:
Disclaimer
This is a licensed product of Koncept Analytics. You cannot reproduce, publish, distribute, publicly display, sell or create other works from this report or use them in any way for commercial purpose without our prior permission. Further, you cannot copy this material, by any means (including electronic copies), for distribution to others unless you have purchased the corporate license of this report. We believe the sources are reliable, but Koncept Analytics does not warranty the accuracy or completeness of the data. The data presented in the report is updated at the publication date but is subject to change at subsequent releases. All possible efforts have been made to ensure accuracy of data. However, investors should not completely rely on the information given in this report and must make decisions based on their own investment strategy, risk management and capital adequacy.
Koncept Analytics CS-36, First Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 T: +91-120-4130959 M: +91-9811715635 vikas@konceptanalytics.com www.konceptanalytics.com
Global Erythropoietin (EPO) Market with Focus on Asia: Industry Analysis & Outlook (2016-2020)
5